サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541733

マラリア診断市場レポート：技術、最終用途、地域別、2024年～2032年

Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.58円
マラリア診断市場レポート：技術、最終用途、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マラリア診断の世界市場規模は2023年に8億2,930万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億8,330万米ドルに達し、2024年から2032年の間に5.7％の成長率（CAGR）を示すと予測しています。

マラリア診断とは、個人の感染の有無を検出するために実施される臨床検査のことです。マラリアは、感染したメスのアノフェレス蚊に刺されることで原虫が体内に侵入することで発症します。一般的な症状としては、発熱、倦怠感、吐き気、頭痛などがあります。感染症は、様々な迅速診断、顕微鏡検査、分子診断検査によって診断されます。これらの検査では、間接免疫蛍光法（IFA）や酵素結合免疫吸着測定法（ELISA）による抗原検出や血清学的手法が用いられます。病院、研究所、診療所、研究機関、診断センターなどで広く使用されています。

マラリア診断の市場動向：

世界中でマラリアの流行が拡大していることは、市場の見通しを明るくする重要な要因の1つです。マラリアは生命を脅かす感染症であり、特に発展途上国において多大な人命損失をもたらしています。しかし、マラリアの診断と治療法に関する大衆の意識の高まりが、市場の成長を後押ししています。ヘルスケアセンターや診断研究所では、さまざまな段階で寄生虫を特定し、適切な治療計画を立案するために顕微鏡診断を広く採用しています。さらに、マラリア診断のための定量バフィーコート（QBC）法や末梢血液塗抹法の開発など、さまざまな技術の進歩も成長を促す要因となっています。これに伴い、精度を高めるためのPOC（Point-of-Care）診断機器が利用可能になったことも、市場の成長に寄与しています。その他、大衆のヘルスケア支出能力の上昇、公衆衛生を促進する政府の好意的な政策の実施などが、市場の成長を促進すると予想されます。

本レポートで扱う主な質問

  • マラリア診断の市場の世界市場規模は？
  • 2024-2032年における世界のマラリア診断の市場の予想成長率は？
  • 世界のマラリア診断の市場を牽引する主要因は何か？
  • 世界のマラリア診断の市場に対するCOVID-19の影響は？
  • 世界のマラリア診断の市場の技術別内訳は？
  • 世界のマラリア診断の市場の最終用途別の内訳は？
  • マラリア診断の市場の世界における主要地域は？
  • マラリア診断の市場の世界における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のマラリア診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • 顕微鏡検査
    • 市場動向
    • 市場予測
  • 迅速診断検査（RDT）
    • 市場動向
    • 市場予測
  • 分子診断検査
    • 市場動向
    • 主要セグメント
      • 従来のPCR
      • リアルタイムPCR（qPCR）
    • 市場予測

第7章 市場内訳：最終用途別

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Access Bio
    • Beckman Coulter Inc.（Danaher Corporation）
    • bioMerieux SA（Compagnie Merieux Alliance）
    • Bio-Rad Laboratories Inc.
    • Nikon Corporation
    • Novartis AG
    • Olympus Corporation
    • Premier Medical Corporation Pvt. Ltd.
    • Siemens Healthcare GmbH（Siemens AG）
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc
図表

List of Figures

  • Figure 1: Global: Malaria Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Malaria Diagnostics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Malaria Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Malaria Diagnostics Market: Breakup by End Use (in %), 2023
  • Figure 6: Global: Malaria Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Malaria Diagnostics (Microscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Malaria Diagnostics (Microscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Malaria Diagnostics (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Malaria Diagnostics (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Malaria Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Malaria Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Malaria Diagnostics (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Malaria Diagnostics (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Malaria Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Malaria Diagnostics Industry: SWOT Analysis
  • Figure 69: Global: Malaria Diagnostics Industry: Value Chain Analysis
  • Figure 70: Global: Malaria Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Malaria Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Malaria Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Malaria Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 4: Global: Malaria Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Malaria Diagnostics Market: Competitive Structure
  • Table 6: Global: Malaria Diagnostics Market: Key Players
目次
Product Code: SR112024A3896

The global malaria diagnostics market size reached US$ 829.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,383.3 Million by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

Malaria Diagnostics Market Trends:

The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and end use.

Breakup by Technology:

Microscopy

Rapid Diagnostic Tests (RDTs)

Molecular Diagnostic Tests

Conventional PCR

Real-Time PCR (qPCR)

Breakup by End Use:

Hospital

Clinics

Diagnostic Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global malaria diagnostics market?
  • 2. What is the expected growth rate of the global malaria diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global malaria diagnostics market?
  • 4. What has been the impact of COVID-19 on the global malaria diagnostics market?
  • 5. What is the breakup of the global malaria diagnostics market based on the technology?
  • 6. What is the breakup of the global malaria diagnostics market based on the end use?
  • 7. What are the key regions in the global malaria diagnostics market?
  • 8. Who are the key players/companies in the global malaria diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Malaria Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Microscopy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Diagnostic Tests (RDTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostic Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Conventional PCR
      • 6.3.2.2 Real-Time PCR (qPCR)
    • 6.3.3 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospital
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Access Bio
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 bioMerieux SA (Compagnie Merieux Alliance)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Nikon Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Novartis AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Olympus Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Premier Medical Corporation Pvt. Ltd.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Siemens Healthcare GmbH (Siemens AG)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sysmex Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Thermo Fisher Scientific Inc
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis